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OSCC is one of the top 10 causes of cancer deaths worldwide, with only a 50% 5-
year survival rate, necessitating the discovery of novel biomarkers and therapeutic 
targets. Using cDNA microarray analyses, we identified expression of a panel of 
kallikreins (KLK 5, 7, 8, and 10) associated with formation of more aggressive OSCC 
tumors in a murine orthotopic OSCC model. The goal of the current study is to 
elucidate the function of KLKs in OSCC progression. In initial studies, KLK levels in 
malignant OSCC cells (SCC25) were compared to cells from normal oral mucosa 
(OKF/6) and pre-malignant oral keratinocytes (pp126) using qPCR. A marked 
elevation of all KLKs was observed in aggressive SCC25 cells relative to OKF/6 
cells. In normal skin, KLKs 5, 7, and 8 are involved in desquamation during 
epidermal differentiation via proteolytic cleavage of the desmosomal cadherin 
component desmoglein 1 (Dsg1). As loss of cell-cell adhesion is prevalent in tumor 
metastasis, Dsg1 was evaluated by immunofluorescence and western blotting. SCC25 
cells exhibit cleavage of Dsg1 which is blocked by treatment with a KLK inhibitor as 
well as by siRNA silencing of KLK5.  Furthermore, cell-cell adhesion and barrier 
function assays demonstrate that silencing of KLK5 enforces cell-cell adhesion and 
improves epithelial barrier function. Current studies are focusing on overexpression 
KLK5 in normal oral mucosal cells (OKF/6) to further evaluate the role of KLK5 in 
desmosomal cadherin processing.  
 
